RESFLOR 300/16.5 MG/ML SOLUTION FOR INJECTION FOR CATTLE
RESFLOR 300/16.5 MG/ML SOLUTION FOR INJECTION FOR CATTLE
Not authorised
- Florfenicol
- Flunixin meglumine
Product identification
Medicine name:
RESFLOR 300/16.5 MG/ML SOLUTION FOR INJECTION FOR CATTLE
RESFLOR 300/16,5 mg/ml ενέσιμο διάλυμα για βοοειδή
Active substance:
- Florfenicol
- Flunixin meglumine
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Florfenicol300.00/milligram(s)1.00millilitre(s)
-
Flunixin meglumine27.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Meat and offal46day
-
Milkno withdrawal periodNo withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01BA99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Cyprus
Package description:
- Carton box containing 250 mL vial
- Carton box containing 100 mL vial
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vet Pharma Friesoythe GmbH
Responsible authority:
- Ministry Of Agriculture Rural Development And Environment
Authorisation number:
- CY00149V
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0167/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 21/11/2023
How useful was this page?:
